Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Non Operating Income: 2010-2024

Historic Non Operating Income for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to $8.1 million.

  • Altimmune's Non Operating Income fell 4.01% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 30.24%. This contributed to the annual value of $8.1 million for FY2024, which is 8.43% up from last year.
  • Latest data reveals that Altimmune reported Non Operating Income of $8.1 million as of FY2024, which was up 8.43% from $7.5 million recorded in FY2023.
  • Over the past 5 years, Altimmune's Non Operating Income peaked at $8.1 million during FY2024, and registered a low of -$374,000 during FY2021.
  • Its 3-year average for Non Operating Income is $6.1 million, with a median of $7.5 million in 2023.
  • Per our database at Business Quant, Altimmune's Non Operating Income slumped by 210.90% in 2021 and then skyrocketed by 856.68% in 2022.
  • Over the past 5 years, Altimmune's Non Operating Income (Yearly) stood at $337,240 in 2020, then plummeted by 210.90% to -$374,000 in 2021, then soared by 856.68% to $2.8 million in 2022, then spiked by 164.38% to $7.5 million in 2023, then increased by 8.43% to $8.1 million in 2024.